http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020138834-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19ba30e3076b9ec9cbcf8beef7a469c8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bbabcf80e679d0959a4670da5e9aa83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c04fc907c32e638db0f5983e57a39b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_764f8e2ad4c433965b56db0edbdbe2d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34bb8089703cf40af023caf575197d98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5e2e577a072e52569ada0a1059581d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba0dc6540aa239e58da8eeed359e868e
publicationDate 2020-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2020138834-A1
titleOfInvention Composition, for osteoarthritis treatment, comprising hydrophilized sulfasalazine and hyaluronic acid and method for preparing same
abstract The present invention relates to a composition for treating osteoarthritis and a method for preparing the same, and more specifically, relates to a composition comprising hydrophilized sulfasalazine as an active ingredient and hyaluronic acid so as to enable effective treatment of osteoarthritis such as degenerative osteoarthritis by preventing joint wear in addition to symptom relief through intraarticular or local administration, and a method for preparing the same. When such a composition for osteoarthritis treatment is prepared by the preparation method according to the present invention, the dissolved state is maintained beyond a neutralization step after dissolution, preventing precipitation of sulfalazine by salting out occurring after neutralization, and thus a composition comprising high concentration of sulfasalazine can be prepared, and the composition prepared accordingly is highly effective in treating osteoarthritis, particularly degenerative osteoarthritis, through the intraarticular or local administration, since it comprises high concentration of sulfasalazine which had to be formulated at low concentration by conventional method due to poor solubility.
priorityDate 2015-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410697574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426079160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226418074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407381940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829

Total number of triples: 58.